|
1
|
Avraamides CJ, Garmy-Susini B and Varner
JA: Integrins in angiogenesis and lymphangiogenesis. Nat Rev
Cancer. 8:604–617. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garmy-Susini B and Varner JA: Roles of
integrins in tumor angiogenesis and lymphangiogenesis. Lymphat Res
Biol. 6:155–163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hogervorst F, Admiraal LG, Niessen C, et
al: Biochemical characterization and tissue distribution of the A
and B variants of the integrin alpha 6 subunit. J Cell Biol.
121:179–191. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Terpe HJ, Stark H, Ruiz P and Imhof BA:
Alpha 6 integrin distribution in human embryonic and adult tissues.
Histochemistry. 101:41–49. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sonnenberg A, Linders CJ, Daams JH and
Kennel SJ: The alpha 6 beta 1 (VLA-6) and alpha 6 beta 4 protein
complexes: tissue distribution and biochemical properties. J Cell
Sci. 96:207–217. 1990.PubMed/NCBI
|
|
6
|
Shaw LM, Messier JM and Mercurio AM: The
activation dependent adhesion of macrophages to laminin involves
cytoskeletal anchoring and phosphorylation of the alpha 6 beta 1
integrin. J Cell Biol. 110:2167–2174. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hallmann R, Horn N, Selg M, Wendler O,
Pausch F and Sorokin LM: Expression and function of laminins in the
embryonic and mature vasculature. Physiol Rev. 85:979–1000. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chung J and Mercurio AM: Contributions of
the alpha6 integrins to breast carcinoma survival and progression.
Mol Cells. 17:203–209. 2004.PubMed/NCBI
|
|
9
|
Zhu GH, Huang C, Qiu ZJ, et al: Expression
and prognostic significance of CD151, c-Met, and integrin
alpha3/alpha6 in pancreatic ductal adenocarcinoma. Dig Dis Sci.
56:1090–1098. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rabinovitz I, Nagle RB and Cress AE:
Integrin alpha 6 expression in human prostate carcinoma cells is
associated with a migratory and invasive phenotype in vitro and in
vivo. Clin Exp Metastasis. 13:481–491. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Delamarre E, Taboubi S, Mathieu S, et al:
Expression of integrin alpha6beta1 enhances tumorigenesis in glioma
cells. Am J Pathol. 175:844–855. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Colomiere M, Findlay J, Ackland L and
Ahmed N: Epidermal growth factor-induced ovarian carcinoma cell
migration is associated with JAK2/STAT3 signals and changes in the
abundance and localization of α6β1 integrin. Int J Biochem Cell
Biol. 41:1034–1045. 2009.PubMed/NCBI
|
|
13
|
Chabut D, Fischer AM, Colliec-Jouault S,
et al: Low molecular weight fucoidan and heparin enhance the basic
fibroblast growth factor-induced tube formation of endothelial
cells through heparan sulfate-dependent alpha6 overexpression. Mol
Pharmacol. 64:696–702. 2003. View Article : Google Scholar
|
|
14
|
Zemani F, Benisvy D, Galy-Fauroux I, et
al: Low-molecular-weight fucoidan enhances the proangiogenic
phenotype of endothelial progenitor cells. Biochem Pharmacol.
70:1167–1175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smadja DM, Bieche I, Helley D, et al:
Increased VEGFR2 expression during human late endothelial
progenitor cells expansion enhances in vitro angiogenesis with
up-regulation of integrin alpha(6). J Cell Mol Med. 11:1149–1161.
2007. View Article : Google Scholar
|
|
16
|
Lee TH, Seng S, Li H, Kennel SJ, Avraham
HK and Avraham S: Integrin regulation by vascular endothelial
growth factor in human brain microvascular endothelial cells: role
of alpha6beta1 integrin in angiogenesis. J Biol Chem.
281:40450–40460. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Primo L, Seano G, Roca C, et al: Increased
expression of alpha6 integrin in endothelial cells unveils a
proangiogenic role for basement membrane. Cancer Res. 70:5759–5769.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bouvard C, Gafsou B, Dizier B, et al:
Alpha6-integrin subunit plays a major role in the proangiogenic
properties of endothelial progenitor cells. Arterioscler Thromb
Vasc Biol. 30:1569–1575. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bouvard C, De Arcangelis A, Dizier B, et
al: Tie2-dependent knockout of α6 integrin subunit in mice reduces
post-ischaemic angiogenesis. Cardiovasc Res. 95:39–47. 2012.
|
|
20
|
Ljubimova JY, Fujita M, Khazenzon NM,
Ljubimov AV and Black KL: Changes in laminin isoforms associated
with brain tumor invasion and angiogenesis. Front Biosci. 11:81–88.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fujita M, Khazenzon NM, Bose S, et al:
Overexpression of beta1-chain-containing laminins in capillary
basement membranes of human breast cancer and its metastases.
Breast Cancer Res. 7:R411–R421. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Germain M, De Arcangelis A, Robinson SD,
et al: Genetic ablation of the alpha 6-integrin subunit in Tie1Cre
mice enhances tumour angiogenesis. J Pathol. 220:370–381. 2010.
|
|
23
|
Ringelmann B, Roder C, Hallmann R, et al:
Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains,
fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ
dy/dy mice. Exp Cell Res. 246:165–182. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sorokin LM, Pausch F, Frieser M, Kroger S,
Ohage E and Deutzmann R: Developmental regulation of the laminin
alpha5 chain suggests a role in epithelial and endothelial cell
maturation. Dev Biol. 189:285–300. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Palma M, Venneri MA, Galli R, et al:
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes
required for tumor vessel formation and a mesenchymal population of
pericyte progenitors. Cancer Cell. 8:211–226. 2005.PubMed/NCBI
|
|
26
|
Coffelt SB, Tal AO, Scholz A, et al:
Angiopoietin-2 regulates gene expression in TIE2-expressing
monocytes and augments their inherent proangiogenic functions.
Cancer Res. 70:5270–5280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Capobianco A, Monno A, Cottone L, et al:
Proangiogenic Tie(2) macrophages infiltrate human and murine
endometriotic lesions and dictate their growth in a mouse model of
the disease. Am J Pathol. 179:2651–2659. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mazzieri R, Pucci F, Moi D, et al:
Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis
by impairing angiogenesis and disabling rebounds of proangiogenic
myeloid cells. Cancer Cell. 19:512–526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Squadrito ML and De Palma M: Macrophage
regulation of tumor angiogenesis: implications for cancer therapy.
Mol Aspects Med. 32:123–145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Welford AF, Biziato D, Coffelt SB, et al:
TIE2-expressing macrophages limit the therapeutic efficacy of the
vascular-disrupting agent combretastatin A4 phosphate in mice. J
Clin Invest. 121:1969–1973. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang H, Lai JY, Do J, et al: Specifically
targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing
monocyte infiltration, and tumor growth. Clin Cancer Res.
17:1001–1011. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stratman AN, Malotte KM, Mahan RD, Davis
MJ and Davis GE: Pericyte recruitment during vasculogenic tube
assembly stimulates endothelial basement membrane matrix formation.
Blood. 114:5091–5101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nolan DJ, Ciarrocchi A, Mellick AS, et al:
Bone marrow-derived endothelial progenitor cells are a major
determinant of nascent tumor neovascularization. Genes Dev.
21:1546–1558. 2007. View Article : Google Scholar : PubMed/NCBI
|
